MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, MRSN made $11,009K in revenue. -$7,545K in net income. Net profit margin of -68.53%.

Income Overview

Revenue
$11,009K
Net Income
-$7,545K
Net Profit Margin
-68.53%
EPS
-$1.51
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Collaboration revenue
11,009 3,056 2,754 12,803
Research and development
12,182 16,218 18,341 20,486
General and administrative
6,303 7,415 8,925 10,223
Restructuring expenses
191 3,940 --
Total operating expenses
18,676 27,573 27,266 30,709
Interest income
516 895 1,164 2,147
Interest expense
394 674 775 953
Total other income, net
122 221 389 1,195
Loss before income taxes
-7,545 ---
Income tax expense
0 --0
Net loss
-7,545 -24,296 -24,123 -16,711
Unrealized gain (loss) on marketable securities, net of tax
0 0 -10 -58
Comprehensive loss
-7,545 -24,296 -24,133 -16,769
Net loss per share attributable to common stockholders basic (in dollars per share)
-1.51 -4.87 -0.19 -0.135
Net loss per share attributable to common stockholders diluted (in dollars per share)
-1.51 -4.87 -0.19 -0.135
Weighted-average number of shares of common stock used in net loss per share attributable to common stockholders basic (in shares)
4,992,639 4,986,784 124,466,113 -61,311,222
Weighted-average number of shares of common stock used in net loss per share attributable to common stockholders diluted (in shares)
4,992,639 4,986,784 124,466,113 -61,311,222
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$7,545K Net loss-$7,545K Interest income$516K Loss before incometaxes-$7,545K Total other income,net$122K Collaboration revenue$11,009K Interest expense$394K Total operatingexpenses$18,676K Restructuring expenses$191K General andadministrative$6,303K Research and development$12,182K

Mersana Therapeutics, Inc. (MRSN)

Mersana Therapeutics, Inc. (MRSN)